Matthew T Plavan has an estimated net worth of $2.11 Million. This is based on reported shares across multiple companies, which include CESCA THERAPEUTICS INC., Arcadia Biosciences, Inc., and Origin Materials, Inc..

2019 was Matthew T Plavan's most active year for acquiring shares with 19 total transactions. Matthew T Plavan's most active month to acquire stocks was the month of July. 2014 was Matthew T Plavan's most active year for disposing of shares, totalling 3 transactions. Matthew T Plavan's most active month to dispose stocks was the month of May. 2011 saw Matthew T Plavan paying a total of $67,500.00 for 155,000 shares, this is the most they've acquired in one year. In 2024 Matthew T Plavan cashed out on 144,500 shares for a total of $182,970.05, their largest year based on trade value.